Envista Holdings Corporation Common stock, $0.01 par value per share

NVSTNYSECIK 1757073Healthcare / Medical Devicesfiscal year ends December36 quarters since 2017

Revenue, Q3 FY2026
$692M
+3.2% on Q3 FY2025
Net income
$508M
+1777.6% on Q3 FY2025
Free cash flow
$62M
−9.0% on Q3 FY2025
Diluted EPS
$3.11
+1827.8% on Q3 FY2025
Revenue, TTM
$2.9B
trailing four quarters
Net margin, TTM
22.0%
net income $634M
Free cash flow, TTM
$242M
$302M less $60M capex
Cash and equivalents
$1.2B
long-term debt $1.4B, Oct 2, 2026
Shares, 12-month change
−2.5%
160M shares, Oct 2, 2026
Buybacks, TTM
—
no yield
Dividends, TTM
—
no yield
Market value
$3.9B
at the close, buybacks

Latest quarter Q3 FY2026, filed November 4, 2026. Trailing figures sum the latest four quarters. Market values at the latest close, from a market data vendor.

In Q3 FY2026, the quarter ended October 2, 2026, Envista Holdings Corporation Common stock, $0.01 par value per share reported revenue of $692M, +3.2% on Q3 FY2025, and net income of $508M (+1777.6%). Operating margin was 74.5%. Free cash flow, operating cash flow less capital expenditures, was $62M ($78M less $16M). Diluted earnings per share were $3.11.

Share price

Daily candlesticks from November 18, 2024 to November 13, 2026, with each earnings release marked; a release after the close marks the day it came out, so its reaction is the next candle. See this earnings season for every company’s reaction.

NVST daily priceSplit-adjusted, US dollars; an earnings release
Nov 13, 2026O $24.76 · H $24.98 · L $24.48 · C $24.49 · −0.69% on the dayOver the range: +23.13%, Nov 14, 2025 to Nov 13, 2026
$18$21$25$28$31Nov 25Jan 26Apr 26Jun 26Sep 26Nov 26

The last 16 quarters

Q4 FY2022 to Q3 FY2026, through the filing of November 4, 2026.

Revenue and net incomeRevenueNet income
−$1.5B−$1.0B−$500M$0$500M$1.0BQ4'22, Revenue: $661MQ4'22, Net income: $74MQ4'22Q1'23, Revenue: $627MQ1'23, Net income: $44MQ1'23Q2'23, Revenue: $662MQ2'23, Net income: $52MQ2'23Q3'23, Revenue: $631MQ3'23, Net income: $22MQ3'23Q4'23, Revenue: $646MQ4'23, Net income: −$217MQ4'23Q1'24, Revenue: $624MQ1'24, Net income: $24MQ1'24Q2'24, Revenue: $633MQ2'24, Net income: −$1.2BQ2'24Q3'24, Revenue: $601MQ3'24, Net income: $8MQ3'24Q4'24, Revenue: $653MQ4'24, Net income: $1MQ4'24Q1'25, Revenue: $617MQ1'25, Net income: $18MQ1'25Q2'25, Revenue: $682MQ2'25, Net income: $26MQ2'25Q3'25, Revenue: $670MQ3'25, Net income: −$30MQ3'25Q4'25, Revenue: $751MQ4'25, Net income: $33MQ4'25Q1'26, Revenue: $706MQ1'26, Net income: $39MQ1'26Q2'26, Revenue: $731MQ2'26, Net income: $54MQ2'26Q3'26, Revenue: $692MQ3'26, Net income: $508MQ3'26−$1.5B−$1.0B−$500M$0$500M$1.0BQ4'22, Revenue: $661MQ4'22, Net income: $74MQ4'22Q1'23, Revenue: $627MQ1'23, Net income: $44MQ1'23Q2'23, Revenue: $662MQ2'23, Net income: $52MQ2'23Q3'23, Revenue: $631MQ3'23, Net income: $22MQ3'23Q4'23, Revenue: $646MQ4'23, Net income: −$217MQ4'23Q1'24, Revenue: $624MQ1'24, Net income: $24MQ1'24Q2'24, Revenue: $633MQ2'24, Net income: −$1.2BQ2'24Q3'24, Revenue: $601MQ3'24, Net income: $8MQ3'24Q4'24, Revenue: $653MQ4'24, Net income: $1MQ4'24Q1'25, Revenue: $617MQ1'25, Net income: $18MQ1'25Q2'25, Revenue: $682MQ2'25, Net income: $26MQ2'25Q3'25, Revenue: $670MQ3'25, Net income: −$30MQ3'25Q4'25, Revenue: $751MQ4'25, Net income: $33MQ4'25Q1'26, Revenue: $706MQ1'26, Net income: $39MQ1'26Q2'26, Revenue: $731MQ2'26, Net income: $54MQ2'26Q3'26, Revenue: $692MQ3'26, Net income: $508MQ3'26−$1.5B−$1.0B−$500M$0$500M$1.0BQ4'22, Revenue: $661MQ4'22, Net income: $74MQ1'23, Revenue: $627MQ1'23, Net income: $44MQ1'23Q2'23, Revenue: $662MQ2'23, Net income: $52MQ3'23, Revenue: $631MQ3'23, Net income: $22MQ3'23Q4'23, Revenue: $646MQ4'23, Net income: −$217MQ1'24, Revenue: $624MQ1'24, Net income: $24MQ1'24Q2'24, Revenue: $633MQ2'24, Net income: −$1.2BQ3'24, Revenue: $601MQ3'24, Net income: $8MQ3'24Q4'24, Revenue: $653MQ4'24, Net income: $1MQ1'25, Revenue: $617MQ1'25, Net income: $18MQ1'25Q2'25, Revenue: $682MQ2'25, Net income: $26MQ3'25, Revenue: $670MQ3'25, Net income: −$30MQ3'25Q4'25, Revenue: $751MQ4'25, Net income: $33MQ1'26, Revenue: $706MQ1'26, Net income: $39MQ1'26Q2'26, Revenue: $731MQ2'26, Net income: $54MQ3'26, Revenue: $692MQ3'26, Net income: $508MQ3'26

Net income losses drawn in red.

Free cash flow
−$50M$0$50M$100M$150MQ4'22, Free cash flow: $93MQ4'22Q1'23, Free cash flow: −$14MQ1'23Q2'23, Free cash flow: $61MQ2'23Q3'23, Free cash flow: $77MQ3'23Q4'23, Free cash flow: $94MQ4'23Q1'24, Free cash flow: $29MQ1'24Q2'24, Free cash flow: $86MQ2'24Q3'24, Free cash flow: $63MQ3'24Q4'24, Free cash flow: $124MQ4'24Q1'25, Free cash flow: −$6MQ1'25Q2'25, Free cash flow: $76MQ2'25Q3'25, Free cash flow: $68MQ3'25Q4'25, Free cash flow: $92MQ4'25Q1'26, Free cash flow: −$16MQ1'26Q2'26, Free cash flow: $104MQ2'26Q3'26, Free cash flow: $62MQ3'26−$50M$0$50M$100M$150MQ4'22, Free cash flow: $93MQ4'22Q1'23, Free cash flow: −$14MQ1'23Q2'23, Free cash flow: $61MQ2'23Q3'23, Free cash flow: $77MQ3'23Q4'23, Free cash flow: $94MQ4'23Q1'24, Free cash flow: $29MQ1'24Q2'24, Free cash flow: $86MQ2'24Q3'24, Free cash flow: $63MQ3'24Q4'24, Free cash flow: $124MQ4'24Q1'25, Free cash flow: −$6MQ1'25Q2'25, Free cash flow: $76MQ2'25Q3'25, Free cash flow: $68MQ3'25Q4'25, Free cash flow: $92MQ4'25Q1'26, Free cash flow: −$16MQ1'26Q2'26, Free cash flow: $104MQ2'26Q3'26, Free cash flow: $62MQ3'26−$50M$0$50M$100M$150MQ4'22, Free cash flow: $93MQ1'23, Free cash flow: −$14MQ1'23Q2'23, Free cash flow: $61MQ3'23, Free cash flow: $77MQ3'23Q4'23, Free cash flow: $94MQ1'24, Free cash flow: $29MQ1'24Q2'24, Free cash flow: $86MQ3'24, Free cash flow: $63MQ3'24Q4'24, Free cash flow: $124MQ1'25, Free cash flow: −$6MQ1'25Q2'25, Free cash flow: $76MQ3'25, Free cash flow: $68MQ3'25Q4'25, Free cash flow: $92MQ1'26, Free cash flow: −$16MQ1'26Q2'26, Free cash flow: $104MQ3'26, Free cash flow: $62MQ3'26

Operating cash flow less capital expenditures; negative quarters in red.

Cash and equivalents against long-term debtCash and equivalentsLong-term debt
$0$500M$1.0B$1.5BQ4'22, Cash and equivalents: $607MQ4'22, Long-term debt: $871MQ4'22Q1'23, Cash and equivalents: $585MQ1'23, Long-term debt: $874MQ1'23Q2'23, Cash and equivalents: $652MQ2'23, Long-term debt: $876MQ2'23Q3'23, Cash and equivalents: $824MQ3'23, Long-term debt: $1.4BQ3'23Q4'23, Cash and equivalents: $940MQ4'23, Long-term debt: $1.4BQ4'23Q1'24, Cash and equivalents: $949MQ1'24, Long-term debt: $1.4BQ1'24Q2'24, Cash and equivalents: $1.0BQ2'24, Long-term debt: $1.4BQ2'24Q3'24, Cash and equivalents: $991MQ3'24, Long-term debt: $1.3BQ3'24Q4'24, Cash and equivalents: $1.1BQ4'24, Long-term debt: $1.3BQ4'24Q1'25, Cash and equivalents: $1.1BQ1'25, Long-term debt: $1.3BQ1'25Q2'25, Cash and equivalents: $1.1BQ2'25, Long-term debt: $1.4BQ2'25Q3'25, Cash and equivalents: $1.1BQ3'25, Long-term debt: $1.4BQ3'25Q4'25, Cash and equivalents: $1.2BQ4'25, Long-term debt: $1.4BQ4'25Q1'26, Cash and equivalents: $1.1BQ1'26, Long-term debt: $1.4BQ1'26Q2'26, Cash and equivalents: $1.1BQ2'26, Long-term debt: $1.4BQ2'26Q3'26, Cash and equivalents: $1.2BQ3'26, Long-term debt: $1.4BQ3'26$0$500M$1.0B$1.5BQ4'22, Cash and equivalents: $607MQ4'22, Long-term debt: $871MQ4'22Q1'23, Cash and equivalents: $585MQ1'23, Long-term debt: $874MQ1'23Q2'23, Cash and equivalents: $652MQ2'23, Long-term debt: $876MQ2'23Q3'23, Cash and equivalents: $824MQ3'23, Long-term debt: $1.4BQ3'23Q4'23, Cash and equivalents: $940MQ4'23, Long-term debt: $1.4BQ4'23Q1'24, Cash and equivalents: $949MQ1'24, Long-term debt: $1.4BQ1'24Q2'24, Cash and equivalents: $1.0BQ2'24, Long-term debt: $1.4BQ2'24Q3'24, Cash and equivalents: $991MQ3'24, Long-term debt: $1.3BQ3'24Q4'24, Cash and equivalents: $1.1BQ4'24, Long-term debt: $1.3BQ4'24Q1'25, Cash and equivalents: $1.1BQ1'25, Long-term debt: $1.3BQ1'25Q2'25, Cash and equivalents: $1.1BQ2'25, Long-term debt: $1.4BQ2'25Q3'25, Cash and equivalents: $1.1BQ3'25, Long-term debt: $1.4BQ3'25Q4'25, Cash and equivalents: $1.2BQ4'25, Long-term debt: $1.4BQ4'25Q1'26, Cash and equivalents: $1.1BQ1'26, Long-term debt: $1.4BQ1'26Q2'26, Cash and equivalents: $1.1BQ2'26, Long-term debt: $1.4BQ2'26Q3'26, Cash and equivalents: $1.2BQ3'26, Long-term debt: $1.4BQ3'26$0$500M$1.0B$1.5BQ4'22, Cash and equivalents: $607MQ4'22, Long-term debt: $871MQ1'23, Cash and equivalents: $585MQ1'23, Long-term debt: $874MQ1'23Q2'23, Cash and equivalents: $652MQ2'23, Long-term debt: $876MQ3'23, Cash and equivalents: $824MQ3'23, Long-term debt: $1.4BQ3'23Q4'23, Cash and equivalents: $940MQ4'23, Long-term debt: $1.4BQ1'24, Cash and equivalents: $949MQ1'24, Long-term debt: $1.4BQ1'24Q2'24, Cash and equivalents: $1.0BQ2'24, Long-term debt: $1.4BQ3'24, Cash and equivalents: $991MQ3'24, Long-term debt: $1.3BQ3'24Q4'24, Cash and equivalents: $1.1BQ4'24, Long-term debt: $1.3BQ1'25, Cash and equivalents: $1.1BQ1'25, Long-term debt: $1.3BQ1'25Q2'25, Cash and equivalents: $1.1BQ2'25, Long-term debt: $1.4BQ3'25, Cash and equivalents: $1.1BQ3'25, Long-term debt: $1.4BQ3'25Q4'25, Cash and equivalents: $1.2BQ4'25, Long-term debt: $1.4BQ1'26, Cash and equivalents: $1.1BQ1'26, Long-term debt: $1.4BQ1'26Q2'26, Cash and equivalents: $1.1BQ2'26, Long-term debt: $1.4BQ3'26, Cash and equivalents: $1.2BQ3'26, Long-term debt: $1.4BQ3'26

Positions at each quarter end, as filed; short-term investments are not included.

Income statement

Last eight quarters, newest first, through Q3 FY2026 filed November 4, 2026.

Envista Holdings Corporation Common stock, $0.01 par value per share income statement, quarterly
Millions of dollarsQ3 FY2026ended Oct 2, 2026filed Nov 4, 2026Q2 FY2026ended Jul 3, 2026filed Aug 5, 2026Q1 FY2026ended Apr 3, 2026filed May 6, 2026Q4 FY2025ended Dec 31, 2025filed Feb 12, 2026Q3 FY2025ended Sep 26, 2025filed Oct 30, 2025Q2 FY2025ended Jun 27, 2025filed Jul 31, 2025Q1 FY2025ended Mar 28, 2025filed May 1, 2025Q4 FY2024ended Dec 31, 2024filed Feb 13, 2025YoYQ3 FY2026vs Q3 FY2025
Revenue692731706751670682617653+3.2%
Cost of revenue291324315340300312281280−2.9%
Gross profit401407390411370370336373+8.2%
Research and development2930303228282527+3.5%
Selling, general and administrative284296298305284295272300−0.1%
Operating income51580637358463946+796.0%
Other income (expense)(7)3(3)(5)12(1)0−614.3%
Pretax income50074525850412937+902.4%
Income tax(8)21142580141135−110.1%
Net income508543933(30)26181+1777.6%
Diluted EPS ($)3.110.330.23—(0.18)0.160.10—+1827.8%
Diluted shares (millions)163164166—166170174——

Fourth quarters are the fiscal year less the first nine months when the filer reports no discrete fourth quarter, and are marked. Diluted EPS is never derived, so a derived quarter shows none. Italic figures are derived.

Balance sheet

Last eight quarters, newest first, through Q3 FY2026 filed November 4, 2026.

Envista Holdings Corporation Common stock, $0.01 par value per share balance sheet, quarterly
Millions of dollarsQ3 FY2026ended Oct 2, 2026filed Nov 4, 2026Q2 FY2026ended Jul 3, 2026filed Aug 5, 2026Q1 FY2026ended Apr 3, 2026filed May 6, 2026Q4 FY2025ended Dec 31, 2025filed Feb 12, 2026Q3 FY2025ended Sep 26, 2025filed Oct 30, 2025Q2 FY2025ended Jun 27, 2025filed Jul 31, 2025Q1 FY2025ended Mar 28, 2025filed May 1, 2025Q4 FY2024ended Dec 31, 2024filed Feb 13, 2025YoYQ3 FY2026vs Q3 FY2025
Cash and equivalents1,1591,1261,0831,2121,1341,1111,0771,069+2.2%
Short-term investments—————————
Total current assets2,0021,9581,9192,0271,9481,9351,8501,788+2.7%
Total assets5,6115,5975,5785,6795,6435,6645,4665,351−0.6%
Total current liabilities816807787853822794873879−0.7%
Long-term debt1,4291,4361,4391,4481,4451,4451,2961,278−1.1%
Total debt1,4291,4361,4391,4481,4451,4451,5281,510−1.1%
Total liabilities—————————
Stockholders’ equity3,0893,0763,0803,1063,0883,1393,0362,935+0.0%
Shares outstanding (millions)160161163164164166169172—

Positions at each period end. Long-term debt is the line the filer tags, with or without its current portion. Total debt is one definition across filers, built from filed lines: long-term debt with its current portion plus short-term borrowings, finance leases where the filer folds them into its debt line, operating leases never; it is blank where the tags do not add up to it. Italic figures are derived.

Cash flow statement

Last eight quarters, newest first, through Q3 FY2026 filed November 4, 2026.

Envista Holdings Corporation Common stock, $0.01 par value per share cash flow statement, quarterly
Millions of dollarsQ3 FY2026ended Oct 2, 2026filed Nov 4, 2026Q2 FY2026ended Jul 3, 2026filed Aug 5, 2026Q1 FY2026ended Apr 3, 2026filed May 6, 2026Q4 FY2025ended Dec 31, 2025filed Feb 12, 2026Q3 FY2025ended Sep 26, 2025filed Oct 30, 2025Q2 FY2025ended Jun 27, 2025filed Jul 31, 2025Q1 FY2025ended Mar 28, 2025filed May 1, 2025Q4 FY2024ended Dec 31, 2024filed Feb 13, 2025YoYQ3 FY2026vs Q3 FY2025
Operating cash flow78119(3)10879890132−1.0%
Capital expenditures16151316111269+49.1%
Free cash flow (CFO − capex)62104(16)926876(6)124−9.0%
Depreciation and amortization2528292929302828−13.0%
Share repurchases—————————
Dividends paid—————————

10-Qs file cash flows as year-to-date totals, so quarterly figures are differenced from consecutive filings and marked. Free cash flow is operating cash flow less capital expenditures, computed from the two filed lines. Italic figures are derived.

Annual statements

Every fiscal year filed, newest first, through FY2025 filed February 12, 2026.

Income statement

Envista Holdings Corporation Common stock, $0.01 par value per share income statement, annual
Millions of dollarsFY2025ended Dec 31, 2025filed Feb 12, 2026FY2024ended Dec 31, 2024filed Feb 13, 2025FY2023ended Dec 31, 2023filed Feb 15, 2024FY2022ended Dec 31, 2022filed Feb 16, 2023FY2021ended Dec 31, 2021filed Feb 24, 2022FY2020ended Dec 31, 2020filed Feb 19, 2021FY2019ended Dec 31, 2019filed Feb 21, 2020FY2018ended Dec 31, 2018filed Oct 24, 2019FY2017ended Dec 31, 2017filed Feb 21, 2020
Revenue2,7202,5112,5672,5692,5091,9292,2852,8452,811
Cost of revenue1,2331,1381,1261,0941,0828749361,2431,190
Gross profit1,4871,3731,4411,4751,4271,0551,3491,6021,621
Research and development114999410010187133172172
Selling, general and administrative1,1571,1581,0571,0561,0209259801,1311,062
Operating income216(1,038)3231930644236298387
Other income (expense)(2)0(23)32(1)23—
Pretax income177(1,085)(55)284255(20)234301387
Income tax130344546(9)(62)507086
Net income47(1,119)(100)24334133218231301
Diluted EPS ($)0.28(6.50)(0.60)1.371.920.201.601.802.35
Diluted shares (millions)169172167178178164136128128

Balance sheet

Envista Holdings Corporation Common stock, $0.01 par value per share balance sheet, annual
Millions of dollarsFY2025ended Dec 31, 2025filed Feb 12, 2026FY2024ended Dec 31, 2024filed Feb 13, 2025FY2023ended Dec 31, 2023filed Feb 15, 2024FY2022ended Dec 31, 2022filed Feb 16, 2023FY2021ended Dec 31, 2021filed Feb 24, 2022FY2020ended Dec 31, 2020filed Feb 19, 2021FY2019ended Dec 31, 2019filed Feb 21, 2020FY2018ended Dec 31, 2018filed Oct 24, 2019FY2017ended Dec 31, 2017filed Feb 21, 2020
Cash and equivalents1,2121,0699406071,0748892110—
Short-term investments—————————
Total current assets2,0271,7881,7441,4251,8361,5911,002787—
Total assets5,6795,3516,6056,5876,5746,8766,1585,8425,993
Total current liabilities8538797811,2371,2081,685709641—
Long-term debt1,4481,2781,3988718839081,3210—
Total debt1,4481,5101,6291,8911,7482,6811,3290—
Total liabilities—————————
Stockholders’ equity3,1062,9354,1744,2074,0583,7213,5404,823—
Shares outstanding (millions)164172172163162160159——

Cash flow statement

Envista Holdings Corporation Common stock, $0.01 par value per share cash flow statement, annual
Millions of dollarsFY2025ended Dec 31, 2025filed Feb 12, 2026FY2024ended Dec 31, 2024filed Feb 13, 2025FY2023ended Dec 31, 2023filed Feb 15, 2024FY2022ended Dec 31, 2022filed Feb 16, 2023FY2021ended Dec 31, 2021filed Feb 24, 2022FY2020ended Dec 31, 2020filed Feb 19, 2021FY2019ended Dec 31, 2019filed Feb 21, 2020FY2018ended Dec 31, 2018filed Oct 24, 2019FY2017ended Dec 31, 2017filed Feb 21, 2020
Operating cash flow276337276183362284398400359
Capital expenditures453458765548787249
Free cash flow (CFO − capex)230303218107307236320328310
Depreciation and amortization116123136138118122120130121
Share repurchases—————————
Dividends paid—————————

Insider activity

Form 4 filings by officers, directors and 10% owners, November 16, 2024 to November 16, 2026. Only open-market purchases and sales count as buys and sells; awards, exercises, tax withholding and gifts are listed in grey and never counted.

Bought, three months
$0
0 purchases by 0 insiders; officers and directors $0
Sold, three months
$220K
1 sales by 1 insider; officers and directors $220K
Bought, twelve months
$0
0 purchases by 0 insiders; officers and directors $0
Sold, twelve months
$510K
3 sales by 1 insider; officers and directors $510K

The last 25 transactions

TradedInsiderRoleTransactionSharesPriceValueHeld afterFiled
Nov 1, 2026Keel Paul AChairman and CEO, Directortax withholding54,197$23.51$1M497,107Nov 2, 2026
Aug 25, 2026Acurio VeronicaPresident, Orthodonticstax withholding7,710$27.47$212K48,806Aug 27, 2026
Aug 25, 2026Befidi RobertPresident, Diagnosticstax withholding5,147$27.47$141K45,785Aug 27, 2026
Aug 25, 2026Hammes Eric D.Chief Financial Officertax withholding10,885$27.47$299K99,913Aug 27, 2026
Aug 25, 2026Nilsson StefanPresident, Nobel Biocaretax withholding804$27.47$22K61,560Aug 27, 2026
Aug 20, 2026Reis MischaSVP, Strategy & Bus. Dev.open-market sale10b5-18,000$27.50$220K27,321Aug 24, 2026
Aug 18, 2026Keel Paul AChief Executive Officer, Directoraward179,730$0.00—551,304Aug 20, 2026
May 25, 2026Keel Paul AChief Executive Officer, Directortax withholding12,811$23.43$300K371,574May 27, 2026
May 19, 2026Carruthers WendyDirectoraward9,330$0.00—59,940May 21, 2026
May 19, 2026Tsingos Christine ADirectoraward9,330$0.00—59,930May 21, 2026
May 19, 2026Jain VivekDirectoraward9,330$0.00—52,945May 21, 2026
May 19, 2026Gallahue KieranDirectoraward9,330$0.00—54,010May 21, 2026
May 19, 2026Pierce James AndrewDirectoraward9,330$0.00—18,485May 21, 2026
May 19, 2026Raskas DanielDirectoraward9,330$0.00—54,010May 21, 2026
May 19, 2026Huennekens R ScottDirectoraward12,585$0.00—82,105May 21, 2026
Feb 25, 2026Hammes Eric D.Chief Financial Officertax withholding2,045$29.59$61K94,743Feb 27, 2026
Feb 25, 2026Hammes Eric D.Chief Financial Officeraward16,055$0.00—110,798Feb 27, 2026
Feb 25, 2026Acurio VeronicaPresident, Orthodonticstax withholding1,412$29.59$42K48,911Feb 27, 2026
Feb 25, 2026Acurio VeronicaPresident, Orthodonticsaward7,605$0.00—56,516Feb 27, 2026
Feb 25, 2026Nilsson StefanPresident, Nobel Biocaretax withholding182$29.59$5K54,759Feb 27, 2026
Feb 25, 2026Nilsson StefanPresident, Nobel Biocareaward7,605$0.00—62,364Feb 27, 2026
Feb 25, 2026Reis MischaSVP, Strategy & Bus. Dev.tax withholding2,976$29.59$88K29,406Feb 27, 2026
Feb 25, 2026Reis MischaSVP, Strategy & Bus. Dev.award5,915$0.00—35,321Feb 27, 2026
Feb 25, 2026Nance Mark EGeneral Counselaward12,675$0.00—81,252Feb 27, 2026
Feb 25, 2026Nance Mark EGeneral Counseltax withholding3,368$29.59$100K68,577Feb 27, 2026

Full insider history for Envista Holdings Corporation Common stock, $0.01 par value per share, or insider activity across all companies. A record of filings, not a recommendation.

Tracked funds holding it

1 of the tracked managers held NVST in their latest 13F filing, through November 12, 2026. Weight is the share of the fund’s reported portfolio. How the funds have traded NVST by quarter.

FundManagerQuarterValueSharesWeightMove
Renaissance TechnologiesPeter BrownQ3 2026$38M2M0.05%added +6.5%

Sources

Fiscal year ends in month 12; periods are labeled with the issuer's own fiscal calendar. Values are as most recently filed (restatements apply; per-share values are on current split basis per the connector's split table, flagged in adjusted). Flow items flagged in `derived` were computed (Q4 = FY − nine months; quarterly cash flow differenced from year-to-date filings) rather than read from a filing. `reconciliation.repaired` lists periods where a full-year figure was filed in a quarter slot: that row was dropped and the quarter rebuilt from the annual figure. `reconciliation.quarantined` lists periods where four filed quarters do not sum to the filed year — those quarterly values are withheld, so a blank there is a withholding rather than an absence of reporting.

Filer
Envista Holdings Corp, CIK 1757073 on EDGAR
Extract generated
November 16, 2026
Withheld
6 line-years whose four quarters do not sum to the filed year: gross profit FY2019, revenue FY2019, cost of revenue FY2020, operating income FY2020, opex sga FY2020, pretax income FY2020
Repaired
1 quarters where a full-year figure was filed in a quarter slot and the quarter was rebuilt: operating income FY2023
XBRL concepts behind each line

Income statement

Revenue: RevenueFromContractWithCustomerExcludingAssessedTax
Cost of revenue: CostOfGoodsAndServicesSold
Gross profit: GrossProfit
Research and development: ResearchAndDevelopmentExpense
Selling, general and administrative: SellingGeneralAndAdministrativeExpense
Operating income: OperatingIncomeLoss
Other income (expense): OtherNonoperatingIncomeExpense
Pretax income: IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
Income tax: IncomeTaxExpenseBenefit
Net income: NetIncomeLoss
Diluted EPS ($): EarningsPerShareDiluted
Diluted shares (millions): WeightedAverageNumberOfDilutedSharesOutstanding

Balance sheet

Cash and equivalents: CashAndCashEquivalentsAtCarryingValue
Short-term investments: not filed
Total current assets: AssetsCurrent
Total assets: Assets
Total current liabilities: LiabilitiesCurrent
Long-term debt: LongTermDebtNoncurrent
Total debt: LongTermDebt, LongTermDebt+short-term, noncurrent, noncurrent+DebtCurrent
Total liabilities: not filed
Stockholders’ equity: StockholdersEquity
Shares outstanding (millions): dei:EntityCommonStockSharesOutstanding

Cash flow statement

Operating cash flow: NetCashProvidedByUsedInOperatingActivities
Capital expenditures: PaymentsToAcquirePropertyPlantAndEquipment
Free cash flow (CFO − capex): not filed
Depreciation and amortization: DepreciationDepletionAndAmortization
Share repurchases: not filed
Dividends paid: not filed

The data

The statements on this page as files, generated November 16, 2026.

JSON file
/data/financials/NVST.json